← Open Payments lookup

PALVINE ALEM: Open Payments

NPI 1780258160 · UPPER MARLBORO, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,401 in 56 payments from 12 companies in 2025. Trend: 2023 $1,565 · 2024 $1,412 · 2025 $1,401

Food & beverage: $1,401
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.9$265
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$206
Vanda Pharmaceuticals Inc.6$164
Neurocrine BioSciences, Inc.3$150
ABBVIE INC.8$145
Lundbeck LLC9$144
Otsuka America Pharmaceutical, Inc.5$136
Alkermes, Inc.4$91
E.R. Squibb & Sons, L.L.C.2$34
Luye Pharma (USA) Ltd.1$24

Products named: CAPLYTA, AUSTEDO XR, REXULTI, HETLIOZ, INGREZZA, VRAYLAR, VIVITROL, ABILIFY ASIMTUFII.

Industry payments across MD — which companies pay providers there.